<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-17881" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Ascites</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Chiejina</surname>
            <given-names>Maria</given-names>
          </name>
          <aff>LSUHSC- Shreveport</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kudaravalli</surname>
            <given-names>Pujitha</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Samant</surname>
            <given-names>Hrishikesh</given-names>
          </name>
          <aff>Ochsner Multiorgan Transplant Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Maria Chiejina declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Pujitha Kudaravalli declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Hrishikesh Samant declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>8</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-17881.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Ascites is the pathologic accumulation of fluid within the peritoneal cavity. It is the most common complication of cirrhosis and occurs in about 50% of patient with decompensated cirrhosis in 10 years. The development of ascites denotes the transition from compensated to decompensated cirrhosis. Mortality increases from complications such as spontaneous bacterial peritonitis and hepatorenal syndrome. Mortality ranges from 15% in a year to 44% in 5 years. This activity describes the evaluation, diagnosis, and management of ascites and highlights the role of team-based interprofessional care for affected patients.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of ascites.</p></list-item><list-item><p>Review the workup of a patient with ascites.</p></list-item><list-item><p>Outline the treatment and management options available for ascites.</p></list-item><list-item><p>Describe interprofessional team strategies for improving care coordination in the evaluation and treatment of ascites to improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17881&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17881">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-17881.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Ascites is the pathologic accumulation of fluid within the peritoneal cavity. It is the most common complication of cirrhosis and occurs in about 50% of patient with decompensated cirrhosis in 10 years. The development&#x000a0;of ascites denotes the transition from compensated to decompensated cirrhosis. Mortality increases from complications&#x000a0;such as spontaneous bacterial peritonitis&#x000a0;and hepatorenal syndrome. Mortality ranges from 15% in a year to 44% in 5 years.<xref ref-type="bibr" rid="article-17881.r1">[1]</xref><xref ref-type="bibr" rid="article-17881.r2">[2]</xref><xref ref-type="bibr" rid="article-17881.r3">[3]</xref></p>
        <p>In most healthy individuals, there is very little free intraperitoneal fluid; some women may have about 20 ml during the menstrual cycle.</p>
      </sec>
      <sec id="article-17881.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>In the United States, the most common disease that causes patients to get&#x000a0;ascites&#x000a0;is cirrhosis, which accounts for approximately 80% of cases. Other causes of ascites include cancer, 10%; heart failure, 3%; tuberculosis, 2%; dialysis, 1%; pancreatic disease, 1%; and others, 2%. Up to 19% of patients with cirrhosis will have hemorrhagic ascites; this may develop spontaneously with 72% of the cases most likely due to bloody lymph and 13% due to hepatocellular carcinoma. It can also develop following paracentesis.<xref ref-type="bibr" rid="article-17881.r4">[4]</xref><xref ref-type="bibr" rid="article-17881.r5">[5]</xref></p>
        <p>Other causes of asictes include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Chronic alcohol use</p>
          </list-item>
          <list-item>
            <p>IV drug use</p>
          </list-item>
          <list-item>
            <p>Obesity</p>
          </list-item>
          <list-item>
            <p>Hypercholesterolemia</p>
          </list-item>
          <list-item>
            <p>Type 2 diabetes</p>
          </list-item>
          <list-item>
            <p>Nephrotic syndrome</p>
          </list-item>
          <list-item>
            <p>Severe malnutrition</p>
          </list-item>
          <list-item>
            <p>Pancreatic ascites</p>
          </list-item>
          <list-item>
            <p>Ovarian lesions</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17881.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Patients with cirrhotic ascites have a 3-year mortality rate of approximately 50%. Refractory ascites carries a poor prognosis, with a 1-year survival rate of less than 50%. Males have little intraperitoneal fluid, females have approximately 20 mL, depending on the phase of their menstrual cycle.</p>
      </sec>
      <sec id="article-17881.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The first abnormality that develops is portal hypertension in the case of cirrhosis. Portal pressure increases above a critical threshold and circulating nitric oxide levels increase, leading to vasodilatation. As the state of vasodilatation becomes worse, the plasma levels of vasoconstrictor sodium-retentive hormones elevate, renal function declines, and ascitic fluid forms, resulting in hepatic decompensation.</p>
        <p>Through the production of proteinous fluid by tumor cells lining the peritoneum,&#x000a0;peritoneal carcinomatosis also can cause ascites. In high-output or low-output heart failure or nephrotic syndrome, effective arterial blood volume is decreased, and the vasopressin, renin-aldosterone, and sympathetic nervous systems are activated, leading to&#x000a0;renal vasoconstriction and sodium and water retention.<xref ref-type="bibr" rid="article-17881.r6">[6]</xref></p>
      </sec>
      <sec id="article-17881.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Patients typically report progressive abdominal distension that may be painless or associated with abdominal discomfort, weight gain, early satiety, shortness of breath, and dyspnea resulting from fluid accumulation and increased abdominal pressure. Symptoms such as fever, abdominal tenderness, and confusion can be seen in spontaneous&#x000a0;bacterial peritonitis.</p>
        <p>Patients with malignant ascites can have symptoms related to malignancy, which may include&#x000a0;weight loss. On the other hand, patients with ascites due to heart failure may report dyspnea, orthopnea, and peripheral edema, and those with chylous ascites report diarrhea, steatorrhea, malnutrition, edema, nausea, enlarged lymph nodes, early satiety, fevers, and night sweats.</p>
        <p>Patients with ascites typically&#x000a0;will&#x000a0;have flank dullness on examination, shifting dullness, a fluid wave, evidence of pleural effusions, and findings related to the underlying cause of the ascites, such as stigmata of cirrhosis (cirrhosis includes spider angioma, palmar erythema, and abdominal wall collaterals.</p>
        <p>Spider angiomata, jaundice, muscle wasting, gynecomastia, and leukonychia are present in patients with advanced liver disease.</p>
        <p>An umbilical nodule that is not bowel or omental, such as a Sister Mary Joseph nodule, provides evidence for cancer as the cause of ascites. In heart failure, physical examination findings may include jugular venous distension, pulmonary congestion, or peripheral edema.</p>
      </sec>
      <sec id="article-17881.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Diagnostic abdominal paracentesis with the appropriate ascitic fluid analysis is probably the most rapid and cost-effective method of diagnosing the cause of&#x000a0;ascites.<xref ref-type="bibr" rid="article-17881.r7">[7]</xref><xref ref-type="bibr" rid="article-17881.r8">[8]</xref></p>
        <p>The initial tests that should be performed on the ascitic fluid include a blood cell count,&#x000a0;with both a total nucleated cell count and polymorphonuclear neutrophils&#x000a0;(PMN) count, and a bacterial culture by bedside inoculation of blood culture bottles.</p>
        <p>Ascitic fluid protein and albumin are measured simultaneously&#x000a0;with the serum albumin level to calculate the serum-ascites&#x000a0;albumin gradient (SAAG).</p>
        <p>The presence of a gradient greater or equal to 1.1&#x000a0;g/dL&#x000a0;(greater or equal to&#x000a0;11&#x000a0;g/L)&#x000a0;predicts that the patient has portal hypertension with 97% accuracy. This is seen in cirrhosis, alcoholic hepatitis, heart failure, massive hepatic metastases, heart failure/pericarditis, Budd-Chiari syndrome, portal vein thrombosis, and idiopathic portal fibrosis. A gradient less than 1.1&#x000a0;g/dL&#x000a0;(less than 11&#x000a0;g/L)&#x000a0;indicates that the patient does not have portal hypertension and occurs in peritoneal carcinomatosis, peritoneal tuberculosis, pancreatitis, serositis, and nephrotic syndrome.</p>
        <p>Additional tests may be performed only if a specific diagnosis is suspected clinically. LDH and glucose level&#x000a0;should be determined&#x000a0;in suspected cases of secondary peritonitis. Other tests to consider include amylase (greater than 1000 U/L suggests pancreatic ascites). Mycobacterial culture should be performed only if tuberculosis is strongly suspected. Other ascitic fluid indices such as lactate and pH offer little to no additional information.</p>
        <p>Chest x-ray may reveal elevated diaphragm.</p>
        <p>Ultrasound is the most sensitive test to detect ascites. It will reveal homogenous freely mobile anechoic collection in the peritoneal cavity. The smallest amount of fluid is usually seen in Morison pouch.</p>
        <p>CT scan can also be used to detect ascites and may also help determine for presence of any masses.</p>
      </sec>
      <sec id="article-17881.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Appropriate treatment of ascites depends on the cause of fluid retention. The goals of therapy in patients with ascites are to minimize the ascitic fluid volume and decrease peripheral edema, without causing intravascular volume depletion.<xref ref-type="bibr" rid="article-17881.r9">[9]</xref><xref ref-type="bibr" rid="article-17881.r10">[10]</xref><xref ref-type="bibr" rid="article-17881.r11">[11]</xref></p>
        <p>Sodium restriction and diuretics form the basis of treatment</p>
        <p>In cases of&#x000a0; high-albumin-gradient ascites which occurs in cirrhosis, the treatment of ascites in these patients&#x000a0; includes abstinence from alcohol, restricting dietary sodium&#x000a0;to 88 mEq (2000 mg)&#x000a0; per day, and treating with diuretics (spironolactone and furosemide&#x000a0;in a ratio of 100:40 mg/day)</p>
        <p>Patient with a treatable liver condition, such as autoimmune hepatitis, chronic hepatitis B with reactivation, hemochromatosis, or Wilson disease, should receive specific therapy for these diseases. Occasionally, cirrhosis due to causes other than alcohol or hepatitis B is reversible; however, these diseases are usually less reversible than in&#x000a0;alcoholic liver disease, and by the time ascites is present, these patients may be better candidates for liver transplantation than for protracted medical therapy.</p>
        <p>Low-albumin-gradient ascites&#x000a0;commonly occurs in non-ovarian peritoneal carcinomatosis. These patients often benefit&#x000a0;from an outpatient therapeutic paracentesis. Patients with ovarian malignancy may benefit from surgical debulking and chemotherapy.&#x000a0;</p>
        <p>TB peritonitis is treated with anti-tuberculous medications, while pancreatic ascites and postoperative lymphatic leak from a distal splenorenal shunt or radical lymphadenectomy may&#x000a0;resolve&#x000a0;spontaneously.</p>
        <p>Chlamydia peritonitis is cured with antibiotics using doxycycline and ascites caused by lupus serositis may respond to glucocorticoids.</p>
        <p>Over the years many types of active and passive pumps have been developed but none works reliably. They are prone to obstruction, mechanical failure, and leaks.</p>
        <p>Therapeutic paracentesis is often done for symptom relief or in patients with tense ascites. Supplements of albumin should be administered at the same time to prevent hypotension. Terlipressin is recommended instead of albumin, if available.</p>
        <p>Transjugular intrahepatic portosystemic shunt is an effective treatment for patients who do not respond to diuretics.</p>
      </sec>
      <sec id="article-17881.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Liver Failure</p>
          </list-item>
          <list-item>
            <p>Biliary disease</p>
          </list-item>
          <list-item>
            <p>Alcoholic liver disease</p>
          </list-item>
          <list-item>
            <p>Cirrhosis</p>
          </list-item>
          <list-item>
            <p>Dilated Cardiomyopathy</p>
          </list-item>
          <list-item>
            <p>Liver cancer</p>
          </list-item>
          <list-item>
            <p>Portal hypertension</p>
          </list-item>
          <list-item>
            <p>Viral hepatitis</p>
          </list-item>
          <list-item>
            <p>Nephrotic syndrome</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17881.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of patients with ascites depends on the cause and chronicity. Disorders that are acute and respond to treatment have a much favorable prognosis, compared to disorders that do not respond.</p>
      </sec>
      <sec id="article-17881.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Spontaneous bacterial peritonitis</p>
        <p>
<bold>Complications related to paracentesis</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Infection</p>
          </list-item>
          <list-item>
            <p>Electrolyte&#x000a0;imbalance</p>
          </list-item>
          <list-item>
            <p>Bowel perforation</p>
          </list-item>
          <list-item>
            <p>Bleeding</p>
          </list-item>
          <list-item>
            <p>Leak of fluid through abdominal wall</p>
          </list-item>
          <list-item>
            <p>Injury to the kidneys</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17881.s12" sec-type="Postoperative and Rehabilitation Care">
        <title>Postoperative and Rehabilitation Care</title>
        <p>Patients with ascites need long-term&#x000a0;monitoring to assess the effectiveness of treatment. The body weight and urinary sodium levels should be monitored in all patients treated with furosemide.</p>
        <p>The goal of treatment is to ensure there is minimal edema&#x000a0;and the patient is able to perform some&#x000a0;daily living activities.</p>
        <p>A low sodium diet is recommended.</p>
      </sec>
      <sec id="article-17881.s13" sec-type="Consultations">
        <title>Consultations</title>
        <list list-type="bullet">
          <list-item>
            <p>Gastroenterologist</p>
          </list-item>
          <list-item>
            <p>Hepatologist</p>
          </list-item>
          <list-item>
            <p>General Surgeon</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17881.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <list list-type="bullet">
          <list-item>
            <p>Limit alcohol intake</p>
          </list-item>
          <list-item>
            <p>Hepatitis B vaccination</p>
          </list-item>
          <list-item>
            <p>Sodium restriction is recommended (2000 mg/d)</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17881.s15" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Transfusion of blood products (fresh frozen plasma or platelets) routinely before paracentesis in patients with cirrhosis and coagulopathy, presumably to prevent hemorrhagic complications, is not supported by data</p>
        <p>Contraindications to paracentesis include&#x000a0;coagulopathy in the presence of DIC,&#x000a0;massive ileus with bowel distension unless the procedure is image-guided to guarantee that the bowel is not entered.</p>
        <p>Complications of ascites may include&#x000a0;but are not limited to&#x000a0;the following:&#x000a0;Spontaneous bacterial peritonitis, cellulitis, tense ascites, pleural effusion, and abdominal wall hernias.</p>
      </sec>
      <sec id="article-17881.s16" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>While it may appear that ascites is a GI related problem, the pathology affects almost all organ systems and has very high morbidity and mortality. Ascites is not a benign disorder and depending on the cause can have a mortality exceeding 20%. <xref ref-type="bibr" rid="article-17881.r12">[12]</xref>To prevent complications and improve the quality of life, a streamlined protocol for management is vital.<xref ref-type="bibr" rid="article-17881.r3">[3]</xref><xref ref-type="bibr" rid="article-17881.r13">[13]</xref> (Level V)</p>
        <p>Countless articles on an interprofessional approach have been published so that the morbidity and mortality can be improved. Besides the gastroenterologist the following interprofessional group of health professionals is highly recommended:</p>
        <list list-type="bullet">
          <list-item>
            <p>Pharmacist to oversee all medications and be alert for drugs that cause liver injury</p>
          </list-item>
          <list-item>
            <p>Nurses to monitor body weight, abdominal girth, prevent deep vein thrombosis, encourage ambulation and educate the patient and family about the importance of a low sodium diet</p>
          </list-item>
          <list-item>
            <p>Internist to monitor coagulation parameters and general health of the patient</p>
          </list-item>
          <list-item>
            <p>Surgeon in case the patient needs decompression of the portal system or a liver transplant</p>
          </list-item>
          <list-item>
            <p>Nephrologist to monitor renal function</p>
          </list-item>
          <list-item>
            <p>Dietitian to promote nutrition</p>
          </list-item>
          <list-item>
            <p>Neurologist to assess mental status</p>
          </list-item>
          <list-item>
            <p>Radiologist to perform TIPS in patients resistant to diuretics</p>
          </list-item>
          <list-item>
            <p>Physical therapist to encourage ambulation</p>
          </list-item>
        </list>
        <p>
<bold>Outcomes and Evidence-based Medicine</bold>
</p>
        <p>Overall the prognosis is much worse for patients who have decompensated cirrhosis compared to those with compensated cirrhosis. Even patients who are ambulatory and have cirrhotic ascites have a 3-year mortality rate of 50%. Patients with refractory ascites have a 1-year survival of less than 50%. There are many evidence-based studies on managing patients with ascites.<xref ref-type="bibr" rid="article-17881.r14">[14]</xref> (Level V). The bottom line is that aggressive care of these patients is critical if one wants to avoid the high mortality. Ascites patients are complex to manage and thus the need for an interprofessional team to ensure that the patient gets the right treatment, including a liver transplant.</p>
      </sec>
      <sec id="article-17881.s17">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17881&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17881">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/gut-health/ascites/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=17881">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/17881/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=17881">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-17881.s18">
        <fig id="article-17881.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Abdominal ascites Contributed by Elisa M. Aponte</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Free__Fluid" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-17881.s19">
        <fig id="article-17881.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Paracentesis, bowel, ascites. Contributed by MyPhuong Mitarai</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Paracentesis__and__needle" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-17881.s20">
        <fig id="article-17881.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Pocket of ascites ideal for paracentesis Contributed by Maria O'Rourke</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="IMG_1727" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-17881.s21">
        <title>References</title>
        <ref id="article-17881.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>HW</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>IK</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jang</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Hwang</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Jeong</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Outcome of endoscopic retrograde cholangiopancreatography in patients with clinically defined decompensated liver cirrhosis.</article-title>
            <source>J Dig Dis</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>19</volume>
            <issue>10</issue>
            <fpage>605</fpage>
            <page-range>605-613</page-range>
            <pub-id pub-id-type="pmid">30126061</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17881.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Privitera</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Figorilli</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Jalan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mehta</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Portosystemic Shunt Embolization and Recurrent Ascites: A Single-Center Case Series.</article-title>
            <source>Gastroenterology</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>155</volume>
            <issue>5</issue>
            <fpage>1649</fpage>
            <page-range>1649-1650</page-range>
            <pub-id pub-id-type="pmid">30118744</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17881.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sarin</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Choudhury</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Management of acute-on-chronic liver failure: an algorithmic approach.</article-title>
            <source>Hepatol Int</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>12</volume>
            <issue>5</issue>
            <fpage>402</fpage>
            <page-range>402-416</page-range>
            <pub-id pub-id-type="pmid">30116993</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17881.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Conangla-Planes</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Serres</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Persiva</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>August&#x000ed;n</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Imaging diagnosis of portal hypertension.</article-title>
            <source>Radiologia (Engl Ed)</source>
            <year>2018</year>
            <season>Jul-Aug</season>
            <volume>60</volume>
            <issue>4</issue>
            <fpage>290</fpage>
            <page-range>290-300</page-range>
            <pub-id pub-id-type="pmid">29472014</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17881.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kibrit</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jung</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Koppe</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Clinical Assessment and Management of Portal Hypertension.</article-title>
            <source>Semin Intervent Radiol</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>35</volume>
            <issue>3</issue>
            <fpage>153</fpage>
            <page-range>153-159</page-range>
            <pub-id pub-id-type="pmid">30087517</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17881.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fukui</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kawaratani</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kaji</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Takaya</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yoshiji</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Management of refractory cirrhotic ascites: challenges and solutions.</article-title>
            <source>Hepat Med</source>
            <year>2018</year>
            <volume>10</volume>
            <fpage>55</fpage>
            <page-range>55-71</page-range>
            <pub-id pub-id-type="pmid">30013405</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17881.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Szkodziak</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Czuczwar</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wrona</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Paszkowski</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Szkodziak</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Wo&#x0017a;niak</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Ascites Index - a novel technique to evaluate ascites in ovarian hyperstimulation syndrome: a concept-proof study.</article-title>
            <source>Ginekol Pol</source>
            <year>2018</year>
            <volume>89</volume>
            <issue>4</issue>
            <fpage>182</fpage>
            <page-range>182-8</page-range>
            <pub-id pub-id-type="pmid">29781072</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17881.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Long</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Koyfman</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>The emergency medicine evaluation and management of the patient with cirrhosis.</article-title>
            <source>Am J Emerg Med</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>36</volume>
            <issue>4</issue>
            <fpage>689</fpage>
            <page-range>689-698</page-range>
            <pub-id pub-id-type="pmid">29290508</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17881.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Burgos</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Thornburg</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Transjugular Intrahepatic Portosystemic Shunt Placement for Refractory Ascites: Review and Update of the Literature.</article-title>
            <source>Semin Intervent Radiol</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>35</volume>
            <issue>3</issue>
            <fpage>165</fpage>
            <page-range>165-168</page-range>
            <pub-id pub-id-type="pmid">30087519</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17881.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adebayo</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Neong</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Refractory Ascites in Liver Cirrhosis.</article-title>
            <source>Am J Gastroenterol</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>114</volume>
            <issue>1</issue>
            <fpage>40</fpage>
            <page-range>40-47</page-range>
            <pub-id pub-id-type="pmid">29973706</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17881.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Storni</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Stirnimann</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Banz</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>De Gottardi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Treatment of Malignant Ascites Using an Automated Pump Device.</article-title>
            <source>Am J Gastroenterol</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>113</volume>
            <issue>7</issue>
            <fpage>1060</fpage>
            <page-range>1060-1061</page-range>
            <pub-id pub-id-type="pmid">29867179</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17881.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Strunk</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Marinova</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Transjugular Intrahepatic Portosystemic Shunt (TIPS): Pathophysiologic Basics, Actual Indications and Results with Review&#x000a0;of the Literature.</article-title>
            <source>Rofo</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>190</volume>
            <issue>8</issue>
            <fpage>701</fpage>
            <page-range>701-711</page-range>
            <pub-id pub-id-type="pmid">30045395</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17881.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Siddique</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Lane-Fall</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>McConnell</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Jakhete</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Crismale</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Porges</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Khungar</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Mehta</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Goldberg</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Schiano</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Regan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Orloski</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Shea</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Exploring opportunities to prevent cirrhosis admissions in the emergency department: A multicenter multidisciplinary survey.</article-title>
            <source>Hepatol Commun</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>2</volume>
            <issue>3</issue>
            <fpage>237</fpage>
            <page-range>237-244</page-range>
            <pub-id pub-id-type="pmid">29507899</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17881.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ede</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Nikolova</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Brand</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Surgical portosystemic shunts versus devascularisation procedures for prevention of variceal rebleeding in people with hepatosplenic schistosomiasis.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2018</year>
            <month>Aug</month>
            <day>03</day>
            <volume>8</volume>
            <issue>8</issue>
            <fpage>CD011717</fpage>
            <pub-id pub-id-type="pmid">30073663</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
